Showing 1,641 - 1,660 results of 99,663 for search '(( 50 ((ppm decrease) OR (nn decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 1641

    Transient neonatal olfactory deprivation causes a persistent decrease in the addition of CR+ PGCs. A by Yasuko Kato (122938)

    Published 2012
    “…The numbers of all three types of cells were significantly decreased by the 8<sup>th</sup> week of naris occlusion (<b>C</b>, red bars, <i>n</i> = 4) compared with the control group (<b>C</b>, blue bars, <i>n</i> = 5). …”
  2. 1642

    Spatial information of excitatory neurons in APP/PS1 mice are decreased in dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…<p>(A) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.134 ± 0.050, APP/PS1 = 0.132 ± 0.054, p < 0.01, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 229 units from 5 recording sessions, n<sub>APP/PS1</sub> = 124 units from 4 recording sessions). …”
  3. 1643
  4. 1644
  5. 1645
  6. 1646
  7. 1647
  8. 1648
  9. 1649
  10. 1650
  11. 1651

    Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

    Published 2012
    “…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”
  12. 1652
  13. 1653
  14. 1654

    Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

    Published 2010
    “…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”
  15. 1655
  16. 1656
  17. 1657
  18. 1658

    Data_Sheet_5_Artesunate Alleviates Paclitaxel-Induced Neuropathic Pain in Mice by Decreasing Metabotropic Glutamate Receptor 5 Activity and Neuroinflammation in Primary Sensory Neu... by Yize Li (471459)

    Published 2022
    “…Artesunate normalized paclitaxel-related expression changes in DRG mGluR5, NR1, and GluA2, as well as six paclitaxel related neuroinflammation markers. …”
  19. 1659

    Sample velocity profile on an decreasing-frequency (DEC) trial. by Jacob A. Yaffe (8298813)

    Published 2020
    “…<p>Shown here is the velocity profile from an decreasing-frequency trial of participant # 21, the only participant in this study who had a confirmed diagnosis of FOG. …”
  20. 1660